Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blis MD vs Hims & Hers

Blis MD
Graded #76

Lower grade

vs+8.5
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 72.5/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBlis MD +5
87
82
Dose & formulationHims & Hers +6
72
78
Clinical oversightHims & Hers +8
74
82
Labs & monitoringHims & Hers +18
62
80
FulfillmentHims & Hers +19
65
84
Contract termsHims & Hers +25
55
80
Blis MD · left barHims & Hers · right bar

The numbers

MetricBlis MDHims & Hers
WeighScore72.5/10081/100
GradeCB−
Scorecard rank#76#36
Semaglutide$139/mo$199/mo
Tirzepatide$199/moNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Blis MD

Graded #76 · C

Strengths

  • Transparent flat monthly pricing published upfront (139 dollars semaglutide, 199 dollars tirzepatide)
  • Free initial virtual consultation with a licensed provider
  • Both semaglutide and tirzepatide offered with ongoing provider check-ins

Where it loses points

  • Compounding pharmacy is not named publicly
  • States served are not listed on the site
  • Thin public trust signals (no LegitScript seal or named medical director found)
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard